14 Nov Madison biotech companies snap up millions in funding from investors
FluGen Inc., a Madison-based firm (And URP tenant) developing a universal flu vaccine, raised $5.58 million in funding through 36 investors, according to the filing. FluGen, which already has investments from Madison’s Venture Investors, the state’s largest venture capital fund, recently shared data from its first test on humans at the annual ID Week conference in San Francisco.